Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2798 of 5804
-
New hope for tough blood cancers: LP-118 trial launches
Disease control Recruiting nowThis is a Phase 1, multi-center, open-label study with a dose-escalation phase (Phase 1a) and a cohort expansion phase (Phase 1b), to evaluate the safety, tolerability, and PK profile of LP-118 under a once daily oral dosing schedule in up to 100 subjects.
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Knee pain relief: synthetic fluid injection shows promise in Long-Term study
Symptom relief Completed1-year follow-up of a randomized controlled trial with open-label extension to assess the long-term efficacy and safety of Intra-articular HBISA Endoprosthesis of Synovial Fluid NOLTREX™ in Knee Osteoarthritis.
Sponsor: Research Centre BIOFORM • Aim: Symptom relief
Last updated Jun 26, 2026 17:39 UTC
-
Experimental antibody drug tested for stubborn blood cancers, but study halted early
Disease control TerminatedThis is a phase II single-center study to evaluate the safety and effectiveness of vibecotamab, a CD3-CD123 bispecific antibody, in patients with acute myeloid leukemia with persistent or recurrent measurable residual disease and in patients with myelodysplastic syndrome that has…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Dance your pain away? study tests aerobic exercise for fibromyalgia
Symptom relief CompletedThe aim of this study was to evaluate the effects of aerobic dance exercises on patients with Fibromyalgia syndrome (FMS) and to compare these effects with those of conventional postural exercises.
Phase: NA • Sponsor: Istanbul University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New tools aim to help women with diabetes plan safer pregnancies
Disease control OngoingThis study is being done to investigate strategies that may improve patient's knowledge of type 2 diabetes during reproductive age and improve knowledge and engagement in self-care activities.
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Migraine showdown: which pill stops the pain faster?
Symptom relief TerminatedIn a real-world population of adults with migraine, the investigators would like to investigate whether 50 mg diclofenac potassium is non-inferior to 75 mg rimegepant in terms of pain freedom at 2 hours after drug intake.
Phase: PHASE4 • Sponsor: Danish Headache Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can VR games help stroke patients regain arm movement?
Symptom relief CompletedPost-stroke rehabilitation is essential for maximising motor recovery. Virtual reality (VR) is emerging as a promising adjunct to conventional therapy (CRT), potentially enhancing upper limb motor outcomes. The goals of the study are: 1. To evaluate the efficiency of VR in addit…
Phase: NA • Sponsor: University Medical Centre Maribor • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Mindfulness may curb diabetes risk in depressed teens
Disease control CompletedRates of type 2 diabetes (T2D) in adolescents have escalated. Adolescent-onset is associated with greater health comorbidities and shorter life expectancy than adult-onset T2D. T2D is preventable by decreasing insulin resistance, a physiological precursor to T2D. T2D prevention s…
Phase: NA • Sponsor: Colorado State University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New study tackles hidden barriers to cancer recovery for black patients
Knowledge-focused OngoingThe objective of the proposed study is to scale social risk factor screening and referral for cancer survivors and to solidify information exchange between clinical and community settings in order to improve survivor health and well-being. This will be completed through three pri…
Phase: NA • Sponsor: Medstar Health Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Zapping away stiffness: TENS shows promise for spinal cord injury spasticity
Symptom relief OngoingThis study examines the immediate and long-term effects of lumbosacral TENS on spasticity and residual voluntary force control in spinal cord injury in comparison to no TENS. Participants in the intervention group will receive 2 months of TENS. Participants in the control group w…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Cutting protein may supercharge cancer fight
Disease control Recruiting nowThe main idea of this study is that a low protein diet may alter the environment surrounding the tumor, enhancing the body's immune response leading to greater anticancer effects of treatment. This study intends to use a low-protein diet as a tool to enhance the immune response g…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Hospital intervention aims to break cycle of youth gun violence
Knowledge-focused Recruiting nowThe goal of the study is to understand if hospital-based violence interventions are effective for reducing youth violence among violently injured youth. This study will allow researchers to learn more about the intervention's effectiveness. The researchers also want to understand…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New program targets exercise fear in heart patients
Symptom relief Recruiting nowBehavioral Exposure for Interoceptive Tolerance (BE-FIT) is a mechanism-informed behavioral intervention to target exercise anxiety. The three primary components of BE-FIT include: (1) exposure to feared bodily sensations and exercise; (2) prevention of safety behavior use before…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
French study checks if new combo works for mesothelioma in everyday practice
Knowledge-focused CompletedMeso-Immune is a retrospective study to assess the efficacy and safety of the combination of Nivolumab and Ipilimumab used in first-line treatment of adult patients with unresectable Malignant Pleural Mesothelioma (MPM). This combination of treatments has been approved in Europe …
Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Donor immune cells take on tough viruses in transplant patients
Disease control Recruiting nowThe primary objective is to determine the safety and feasibility of administering R-MVST cells to patients with refractory viral reactivation and/or symptomatic disease caused by Epstein Barr Virus (EBV), cytomegalovirus (CMV), adenovirus (ADV) or BK virus. R-MVST cells will be g…
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a phone app help women with HIV overcome stigma and stick to treatment?
Disease control Recruiting nowThe purpose of this study is: 1. To develop a new mobile health (mHealth) system that will send text messages to remind both pregnant and non-pregnant women with HIV to adhere to their treatment plan (like keeping appointments, fillings prescriptions, and taking their medication…
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Diet and exercise may cut heart risks for breast cancer patients on hormone therapy
Disease control CompletedThis study aims to evaluate body weight status, lifestyle patterns, and cardiometabolic risk in women in remission from breast cancer undergoing adjuvant hormone therapy, and to assess the effects of a structured nutritional intervention based on the Mediterranean diet combined w…
Phase: NA • Sponsor: MOHAMEDI Ilhem Sarra Manel • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Soybean oil shows promise for fatty liver – no weight loss needed
Disease control OngoingThe research study is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in hepatic lipid accumulation, visceral adipose tissue and postprandial lipid, markers of inflammation and energy metabolism in participants who consume 3 study foods per…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Phone calls after heart surgery cut symptoms and boost Self-Care, study finds
Symptom relief CompletedIt was planned as randomized controlled experimental study to examine the effect of post discharge telenursing counseling on symptom control and self-care in patients who undergoing coronary artery bypass graft surgery. The research was carried out between July 2022 and July 202…
Phase: NA • Sponsor: Fenerbahce University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Celiac Kids' diet under the microscope: new study seeks better ways to track health
Knowledge-focused CompletedThe only treatment for celiac disease (CD) consists of following a strict lifelong gluten-free diet, which may lead to potential dietary imbalances and associated diseases. Although individualized dietary counseling should be mandatory for people with celiac disease, they often d…
Phase: NA • Sponsor: University of the Basque Country (UPV/EHU) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC